Befejeződött1. fázis
A study of the safety, tolerability, biological effect, and efficacy of allogenic natural killer cells in combination with trastuzumab and pertuzumab in adult patients with refractory metastatic Her2 positive breast cancer
Key facts
- Where
- Barcelona, SpanyolországSee the 2 sites
- Phase
- 1. fázis
Where in Spanyolország
- Hospital del MarBarcelona, SpanyolországNo longer taking part
- Hospital Universitari Vall d'HebronBarcelona, SpanyolországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Vall D Hebron Institute Of Oncology
- Trial code
- EU 2024-516692-32-00
- Record updated
- 2025. február 19.